NewsRoom Articles - Page 54 of 154 - PsychedelicNewsWire (PNW)

ThursdayJul 21, 2022 12:06 pm

Study Says Ayahuasca Users Tend to Exercise More, Eat Healthier

A new study has found that individuals who regularly use ayahuasca engage in a range of positive health behaviors that result in mental and physical health benefits. Ayahuasca is an entheogenic and psychedelic mixed brew that was traditionally used by the ancient Amazonian tribes in South America during religious ceremonies. In recent times, however, the brew has become popular due to its hallucinogenic effects and mental health benefits. Jose Carlos Bouso, the author of the study, stated that despite the growing popularity of the substances, some nations were prosecuting the use of ayahuasca. The study’s objective was to look into…

WednesdayJul 20, 2022 11:52 am

House Approves Amendments on Psychedelic Therapy in Defense Spending Measure

Research from recent years has revealed that psychedelic drugs have the potential to revolutionize mental health treatment. Psychedelics are federally classified as Schedule I drugs with no medical potential, however, making it nigh impossible for the people who would benefit from psychedelic treatments to access them. Fortunately, this may soon change after the U.S. House of Representatives passed psychedelic therapy amendments that would expand research into the benefits of psychedelics and allow veterans to access psychedelic-assisted PTSD treatments. The bipartisan amendments by Reps. Alexandria Ocasio-Cortez and Dan Crenshaw would increase access to psychedelics treatments for military veterans as well as…

TuesdayJul 19, 2022 1:04 pm

The DEA Could Be Sued Again Over Stance on Psilocybin, Cancer Patients

More than a year ago, a Seattle doctor and several cancer patients sued the U.S. Drug Enforcement Administration after the federal agency sent a letter declaring that the patients could not access synthetic psilocybin under federal and state right-to-try laws. These legislations grant patients with terminal illnesses the right to use experimental drugs that haven’t yet been approved for public use. The U.S. Court of Appeals for the Ninth Circuit dismissed the suit in February, stating that it did not have jurisdiction because the letter sent by the DEA wasn’t a final rule. However, the DEA could soon be sued…

MondayJul 18, 2022 12:19 pm

Experts Recommend Thinking Long Term When Investing in Psychedelics

We have seen the psychedelic industry grow significantly the last few years as investing companies pour more money into the burgeoning space and organizations respond to the global mental disorder epidemic. A Lancet study found that the worldwide pandemic has impacted individuals’ mental health significantly, with data showing that more than 75 million instances of anxiety disorders and more than 53 million additional major depressive disorder cases have been recorded. In the United States, the psychedelics industry is advancing rapidly after states such as California, Texas, New Jersey, Connecticut, Missouri and Utah made strides to legalize or decriminalize psychedelic drugs.…

FridayJul 15, 2022 11:32 am

Study Finds That Microdosing Psilocybin Mushrooms Improves Mood, Mental Health

New research has found evidence suggesting that magic mushrooms can improve the mood and mental health of an individual. The study analyzed about 1,100 subjects, with baseline evaluations being carried out at the start of the study then again between three or five weeks later. For their research, investigators analyzed the results of psilocybin microdoses combined with vitamin-B3 (niacin) or lion’s mane mushrooms. The researchers’ objective was to identify any improvement in mental health and mood that was consistent across presence of mental health concerns, age and gender as well as improvements in psychomotor performance, which were specific to older…

ThursdayJul 14, 2022 12:26 pm

Is It Safe to Smoke DMT?

DMT is said to be one of the most potent hallucinogens known to man. Smoking this drug, which is also called the spirit molecule, can cause a range of hallucinations, including visions of alien landscapes, temples, clowns, fairies, sprites, elves and goddesses. Nick Sand, an underground chemist, discovered in the 1960s that DMT was hallucinogenic when smoked, noting that what the drug opened humans up to was profound. In the 1990s, the drug’s reputation was changed when Terence McKenna, a psychedelic philosopher and author, lectured audiences about the drug’s hyperspaces. This was soon followed by a book on DMT, which…

WednesdayJul 13, 2022 3:48 pm

States That Have Made Advancements Toward Legalizing Psychedelics

Interest in psychedelics has grown significantly as mainstream acceptance grows and research uncovers more of the benefits that these substances possess, including how they can be used to manage a range of mental health disorders. These positive advancements have even led some states to decriminalize these controlled substances, with other states set to legalize the substances in the near future. Let’s look at some of the states that may soon legalize psychedelics. Oregon In November 2020, the state of Oregon passed a measure that would establish legal psychedelic healing centers where individuals aged 21 and above could undergo psilocybin-assisted therapy.…

WednesdayJul 13, 2022 9:00 am

Homing Peptides: Silo Pharma Inc. (SILO) Targets ADRs

Silo’s partnership with UMB could yield therapeutics that limit side effects through precisely targeted delivery On February 3, 2022, Silo Pharma (OTCQB: SILO) extended its research partnership with the University of Maryland, Baltimore (“UMB”) to explore potentially lifesaving joint-homing peptides that target inflamed endothelium (a thin membrane that lines the inside of the heart and blood vessels). The ability to target inflamed tissue (while bypassing healthy organs) suggests joint-homing peptides could deliver therapeutics or fusion imaging nanoparticles to specific diseased tissues. Better imaging, lower radiation and precision, targeted dosing could enhance the therapeutic effect of current and future therapeutics and…

TuesdayJul 12, 2022 3:58 pm

DEA Sets Hearing Date Regarding Plan to Ban Several Psychedelics

In January, the Drug Enforcement Administration announced a proposed ban on five psychedelics: 4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET and DiPT. With the country going through what some have called a psychedelics renaissance, the agency received significant criticism for its proposed decision. As such, the DEA stated in a recent notice that it will be holding a hearing on Aug. 22, 2022, to listen to testimonies from individuals who were “adversely aggrieved or affected” by its proposed ban. The agency received plenty of backlash from researchers and advocates at the start of the year when it first proposed the ban. According to…

MondayJul 11, 2022 1:42 pm

Congressional Leaders Want Studies to be Conducted on Mental Health Benefits of Psychedelics

Initial research on psychedelics back in the 1950s and 1960s found that treatments involving psychedelic drugs could lead to positive mental health outcomes. However, the U.S. government criminalized psychedelics in the late 1960s. The substances remained illegal for decades until a few states began loosening their own psychedelic policies in recent years. With psychedelics seeing a resurgence in mainstream and scientific interest, Congressional leaders are calling for more research on the potential of psychedelic drugs to treat debilitating mental health conditions such as post-traumatic stress disorder (PTSD) and depression. For example, House Appropriations Committee leaders have included provisions for spending…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000